GSA Capital Partners LLP Makes New Investment in InfuSystem Holdings, Inc. $INFU

GSA Capital Partners LLP purchased a new stake in InfuSystem Holdings, Inc. (NYSE:INFU) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 160,439 shares of the company’s stock, valued at approximately $1,548,000.

Several other large investors have also recently made changes to their positions in INFU. Cubist Systematic Strategies LLC acquired a new position in InfuSystem during the first quarter worth $129,000. Jane Street Group LLC purchased a new stake in InfuSystem during the first quarter worth about $96,000. Acadian Asset Management LLC increased its stake in InfuSystem by 219.1% during the first quarter. Acadian Asset Management LLC now owns 39,117 shares of the company’s stock worth $208,000 after purchasing an additional 26,860 shares during the period. American Century Companies Inc. lifted its position in shares of InfuSystem by 147.4% during the second quarter. American Century Companies Inc. now owns 117,812 shares of the company’s stock worth $735,000 after purchasing an additional 70,188 shares in the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of InfuSystem during the second quarter worth about $185,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Price Performance

INFU stock opened at $12.27 on Monday. InfuSystem Holdings, Inc. has a one year low of $7.29 and a one year high of $12.97. The company has a 50 day moving average price of $9.86 and a two-hundred day moving average price of $9.39. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The stock has a market capitalization of $247.63 million, a P/E ratio of 204.53 and a beta of 1.42.

InfuSystem announced that its board has approved a stock repurchase plan on Tuesday, May 19th that allows the company to repurchase $20.00 million in shares. This repurchase authorization allows the company to reacquire up to 10.2% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

Separately, B. Riley Financial reissued a “buy” rating and issued a $20.00 price objective (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $16.67.

InfuSystem Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.